Chinese-Language Podcast: AZ收购亘喜，MNC本土重磅交易，2024展望
China Cell Therapy M&A, 2024 Outlook
One week into 2024 and there have already been multiple deals between Chinese innovative drug developers and multinational partners, along with the significant acquisition of GracellBio by AstraZeneca. In this Chinese-language podcast, Brian Yang and Dexter Yan invite a guest speaker to discuss the reasons behind the particularly active China biotech deal-making scene.
